Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000894579-10-000093
Filing Date
2010-06-04
Accepted
2010-06-04 19:32:02
Documents
1
Period of Report
2010-05-28

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 11540
  Complete submission text file 0000894579-10-000093.txt   13856
Mailing Address 4673 CHRISTOPHER PLACE DALLAS TX 75204
Business Address
AUSTIN JOSIAH T (Reporting) CIK: 0000932267 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51462 | Film No.: 10880104

Mailing Address 4673 CHRISTOPHER PLACE DALLAS TX 75204
Business Address 4673 CHRISTOPHER PLACE DALLAS TX 75204 214-520-1684
El Coronado Holdings, LLC (Reporting) CIK: 0001319763 (see all company filings)

State of Incorp.: AZ | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 000-51462 | Film No.: 10880103

Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Issuer) CIK: 0001333763 (see all company filings)

EIN.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)